1Lemos P,Saia F, Hofma S, et al. Short-and longterm clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol,2004, 43,704-708.
2Nordmann A, Hengstler P, Harr T, et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a recta-analysis of randomized controlled trials. Am J Med,2004,116:253 262.
3Sleeper L, Ramanathan K, Lejemtel T, et al. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. SHOCK Investigators. J Am Coil Cardiol, 2005,46 : 266-273.
4De Luca G,Suryapranata H, Ottervanger JP, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation, 2004, 109.. 1223-1225.
5De Luca G, van't Hof AW, de Boer M J, et al. Time-to-treatment significantly affects the extent of ST-segmet resolution and myocardial blush in patients with acute mycardial infarction treated by primary angioplasty. Eur Heart J, 2004,25 : 1009-10013.
6Sabatine M, Cannon C, Hibson C, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST- segment elevation. N Engl J Med,2005,352..l179-1189.
7Gersh B, Stone G, White H, et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA, 2005,293 : 979-986.
8Amish C, Mark D, Kelemen. Early Management of ST-segment Elevation Myocardial Infarction. Cardiol Clin, 2006,24 : 37-51.
